TMS vs Neuroplastic Pain: Same Condition, Different Names

Published March 7, 2026 · 9 min read

By Tauri Urbanik, Pain Science Researcher

What is the difference between TMS and neuroplastic pain?

If you've spent any time in chronic pain communities, you've probably noticed the terminology wars. Some people swear by "TMS." Others insist on "neuroplastic pain." Some use "MBS" or "PPD." And the medical establishment uses "nociplastic pain."

Here's the short answer: they all describe the same thing. Chronic pain generated by brain processes rather than structural tissue damage.

Here's the longer answer: why the name changed tells you something important about how understanding has evolved. And understanding that evolution can actually help your recovery.

Dr. Sarno coined Tension Myositis Syndrome in the 1970s and 1980s. He proposed a specific mechanism: repressed emotions trigger the autonomic nervous system to constrict blood vessels, reducing oxygen to muscles (that's the "myositis," muscle inflammation, though he later acknowledged it wasn't quite inflammation). The oxygen deprivation creates real pain in muscles, tendons, and nerves.

Alan Gordon popularized "neuroplastic pain" through his 2021 book The Way Out. He proposed a different mechanism: the brain's predictive processing system learns to interpret safe body signals as dangerous, generating pain as a false alarm. The fear-pain cycle perpetuates the pattern. The solution is retraining the brain through somatic tracking and safety reappraisal.

Both Sarno and Gordon agree on the fundamentals. Chronic pain is brain-generated. The body isn't damaged. Recovery requires changing the brain's pain processing, not fixing the body. Their disagreement is about the intermediate mechanism and the treatment details. And honestly, modern neuroscience suggests elements of both are correct.

The terminology timeline

Understanding how the names evolved helps make sense of the field:

TMS: Tension Myositis Syndrome (Sarno, 1970s-80s). The original term. Emphasized muscle tension and the role of emotional pressure. Later updated to Tension Myoneural Syndrome to include nerve involvement.

MBS: Mind Body Syndrome (Schubiner, ~2010). Schubiner proposed this as a more descriptive, less mechanistically specific term. It acknowledges the mind-body connection without committing to Sarno's vasoconstriction hypothesis.

PPD: Psychophysiologic Disorder (working group, 2010). A formal working group including Schubiner, Gordon, and others proposed this clinical term. It's the most medically precise: a physical disorder with psychological origins.

Nociplastic Pain (IASP, 2017). The International Association for the Study of Pain officially adopted this as the third mechanistic category of chronic pain, alongside nociceptive (injury-based) and neuropathic (nerve damage) (Kosek et al., PAIN, 2016↗). This was the medical establishment's acknowledgment that pain can arise without tissue damage or nerve lesions.

Neuroplastic Pain (Gordon, 2021). Gordon's preferred term, emphasizing the brain's capacity for change (neuroplasticity). It's the most accessible modern term and has been widely adopted outside the TMS community.

Each name represents a step in the same direction: moving from a specific theoretical framework (TMS) toward broader scientific terminology (neuroplastic/nociplastic pain). The phenomenon stayed the same. The language evolved to reflect better understanding.

Where TMS and modern approaches differ

The core insight is shared. The details diverge in some meaningful ways.

The mechanism debate

Sarno proposed that repressed rage triggers the autonomic nervous system to restrict blood flow, creating oxygen deprivation in targeted tissues. This mechanism has never been directly confirmed through research. But the clinical outcomes Sarno achieved suggest something real was happening.

Modern neuroscience explains chronic pain through central sensitization (Woolf, PAIN, 2011↗). The brain's pain processing system becomes amplified, interpreting normal signals as threatening. Neural pathways that carry pain signals get strengthened through repetition, like any other learned pattern. Fear, attention, and belief reinforce these pathways.

The modern explanation is better supported by research. But it's worth noting that Sarno's clinical insight was correct even if his proposed mechanism was imprecise. He identified the right problem (brain-generated pain) and the right solution (change the brain's processing) decades before the neuroscience caught up.

The treatment debate

Sarno said knowledge alone could cure TMS. Read the book, understand the mechanism, accept the diagnosis, and the pain loses its purpose. His 12 Daily Reminders reinforced this understanding daily. He told patients to stop all physical treatments and resume full activity immediately.

Gordon's Pain Reprocessing Therapy is more structured. Somatic tracking provides a specific technique for engaging with pain sensations. Safety reappraisal gives a framework for building evidence. Corrective experiences systematically challenge the brain's danger predictions. The Boulder study validated this approach with 66% of patients becoming pain-free (Ashar et al., JAMA Psychiatry, 2022↗).

Schubiner's EAET adds structured emotional processing. His clinical trials showed emotional awareness and expression therapy outperformed CBT for fibromyalgia by nearly three to one (Lumley et al., PAIN, 2017↗).

The reality: these aren't competing approaches. They're complementary layers. Knowledge (Sarno) + fear reduction (Gordon) + emotional processing (Schubiner) addresses the problem from multiple angles. Many recovered patients used elements of all three.

The community divide

The TMS vs. neuroplastic pain terminology debate isn't just academic. It reflects a real divide in the community.

TMS purists argue that Sarno got it right, that the framework doesn't need updating, and that renaming the condition dilutes his legacy. They point out that Sarno's patients recovered at impressive rates without somatic tracking or EAET. Writers like Steve Ozanich and long-standing TMS community members tend to hold this position.

Integrators argue that modern neuroscience has refined the understanding, that updated terminology makes the approach more accessible to skeptics and mainstream medicine, and that techniques like somatic tracking are genuine advances, not just rebranding. Practitioners like Gordon, Schubiner, and the team behind Curable generally take this view.

Both sides have legitimate points. Sarno deserves credit for identifying the phenomenon decades before the establishment caught up. But medicine evolves. Terminology evolves. Techniques evolve. Using "neuroplastic pain" doesn't erase Sarno's contribution. It builds on it.

As one TMS community member put it, "neuroplastic" simply describes the mechanism in terms that appeal to a logical, evidence-minded audience. That's not a betrayal of Sarno. It's an extension of his work.

For you, the person in pain, the terminology debate is background noise. What matters is: do you understand that your brain is generating your pain? Are you doing the daily work to change that? Everything else is commentary.

From understanding to action

Whether you found this page through TMS searches or neuroplastic pain searches, the path forward is the same.

Read widely. Healing Back Pain gives you Sarno's original framework. The Way Out gives you Gordon's modern version. They're complementary, not competing. Many people read both and take what resonates from each.

Pick a daily practice. Sarno's daily reminders. Gordon's somatic tracking. Schubiner's 28-day program. Buglio's mindset work. Sachs' JournalSpeak. These are all valid daily practices. Pick one. Do it every day. Consistency matters more than which technique you choose.

Track your patterns. Daily pain tracking reveals the stress-pain correlations that prove, with your own data, that your pain is brain-generated. Watching your pain fluctuate with your emotional state rather than your physical activity is some of the most powerful evidence you'll encounter.

Connect with community. The TMS Wiki, Reddit, Facebook groups, and practitioner communities offer support and shared experience. Hearing from others who recovered normalizes your experience and builds hope.

For people who want structured daily practice, tools like PainApp offer pain tracking that reveals TMS/neuroplastic patterns, condition-specific audio courses, and an AI-powered Pain Coach. It bridges both communities by building on the science Sarno identified and the techniques modern practitioners refined.

Frequently asked questions

Is TMS the same as neuroplastic pain?

Yes. TMS (Tension Myositis Syndrome) and neuroplastic pain describe the same fundamental condition: chronic pain generated by brain processes rather than structural tissue damage. The terminology evolved as scientific understanding deepened, but the core phenomenon is identical.

What is the difference between Sarno's approach and Alan Gordon's PRT?

Sarno focused on repressed rage as the driver and knowledge as the cure. Gordon focuses on the fear-pain cycle and uses somatic tracking to retrain the brain's danger response. Gordon's approach is backed by a 2022 JAMA trial. Both work from the same core insight that pain is brain-generated.

Should I use TMS or neuroplastic pain terminology?

Use whichever term resonates with you. TMS connects you to Sarno's community and decades of patient experience. Neuroplastic pain connects you to modern neuroscience research. Many practitioners use both. The recovery work is the same regardless of terminology.

Why did the name change from TMS to neuroplastic pain?

Several reasons. TMS is easily confused with Transcranial Magnetic Stimulation. Sarno's proposed mechanism (oxygen deprivation) has been refined. Neuroplastic pain better reflects current neuroscience understanding of how the brain generates and maintains pain patterns. The medical establishment adopted nociplastic pain in 2017.

References

1. Ashar YK, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):13-23.DOI: 10.1001/jamapsychiatry.2021.2669
2. Kosek E, et al. Do we need a third mechanistic descriptor for chronic pain states? PAIN. 2016;157(7):1382-1386.
3. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. PAIN. 2011;152(3 Suppl):S2-S15.DOI: 10.1016/j.pain.2010.09.030
4. Lumley MA, et al. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. PAIN. 2017;158(12):2354-2363.DOI: 10.1097/j.pain.0000000000000749